期刊文献+

持续气道正压通气治疗对阻塞性睡眠呼吸暂停—低通气综合征患者血浆一氧化氮、内皮素1和可溶性P选择素水平的影响 被引量:7

Effect of Continuous Positive Airway Pressure Treatment on Blood Concentration of Nitric Oxide,Endothelin-1 and Soluble P-Selectin in Patients with Obstructive Sleep Apnea/Hyponea Syndrome
下载PDF
导出
摘要 目的探讨阻塞性睡眠呼吸暂停/低通气综合征患者血浆一氧化氮、内皮素1和可溶性P选择素水平的变化及持续气道正压通气治疗对其的影响。方法持续气道正压通气治疗前后分别采用硝酸盐还原酶法、放射免疫均相竞争分析法和酶联免疫法测定阻塞性睡眠呼吸暂停—低通气综合征患者血一氧化氮、内皮素1和可溶性P-选择素水平。结果阻塞性睡眠呼吸暂停/低通气综合征患者血一氧化氮水平(63.41±27.68μmol/L)明显低于健康对照者(83.26±47.74μmol/L),内皮素1水平(71.56±23.33μg/L)和可溶性P选择素水平(131.13±77.93mg/L)明显高于健康对照者(58.49±15.02μg/L和32.90±55.73mg/L);但阻塞性睡眠呼吸暂停/低通气综合征患者血一氧化氮水平明显高于伴有心脑血管疾病患者(59.59±34.19μmol/L),内皮素1水平和可溶性P选择素水平明显低于伴有心脑血管疾病患者(89.01±44.87μg/L和160.83±125.45mg/L)。持续气道正压通气治疗可明显提高一氧化氮水平(60.46±23.53μmol/L比75.11±23.91μmol/L)、降低内皮素1(73.60±20.78μg/L比61.84±18.79mg/L)和可溶性P选择素(137.34±90.35μg/L比89.56±34.60mg/L)水平(P<0.05)。结论阻塞性睡眠呼吸暂停/低通气综合征患者无论是否合并心脑血管疾病,血浆一氧化氮、内皮素1和可溶性P选择素均存在明显异常;而持续气道正压通气治疗可有效纠正其异常。 Aim To observe the levels of nitric oxide, endothelin- 1 and soluble P-selectin in patients with obstructive sleep apnea/hyponea syndrome and determine whether continuous positive airway pressure treatment has effect on them. Methods Blood concentration of nitric oxide, endothelin-1 and soluble P-selectin, the markers of vascular endothelial cell function, were determined by nitrate reduetase, radioimmunoassay, and enzyme-linked immunoassay, respectively. Results Compared with healthy controls (83.26± 47.74μmol/L, 58.49±15.02 ng/L and 32.90±55.73 mg/L; respectively), the levels of nitric oxide, endothelin-1 and soluble P-selectin both in patients without cardiovascular disease (63.41 ± 27.68μmol/L, 71.56±23.33 ng/L and 131.13±77.93 mg/L; P〈 0.05) and in those with cardiovascular disease (59.59± 34.19μmol/L, 89.01 ± 44.87 ng/L and 160.83 ± 125.45 mg/L; P 〈 0.05) were significantly changed. However, after continuous positive airway pressure treatment, the blood concentration of nitric oxide ( 60.46 ± 23.53 μmol/L vs 75.11 ± 23.91 /nnol/L; P = 0. 025 ), endothelin- 1 ( 73.60 ± 20.78 ng/L vs 61.84 ± 18.79 ng/L; P = 0.031 ) and soluble P-selectin ( 137.34 ± 90.35 mg/L vs 89.56 ± 34.60 mg/L; P = 0. 013 ) were significantly improved. Conclusions Obstructive sleep apnea/ hyponea syndrome patients, no matter whether complicated by cardiovascular diseases or not, have significant vascular endothelial cell dysfunction, which can be improved through the continuous positive airway pressure treatment.
机构地区 浙江医院呼吸科
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第1期54-56,共3页 Chinese Journal of Arteriosclerosis
基金 浙江省医药卫生科学研究基金(2003B018)
关键词 内科学 持续气道正压通气 睡眠呼吸暂停综合症 一氧化氮 内皮素1 P选择素 Continuous Positive Airway Pressure Sleep Apnea Syndrome Nitric Oxide Endothelin-1 P-Selectin
  • 相关文献

参考文献17

  • 1Peker Y,Hedner J,Norum J,Kraiczi H,Carlson J.Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea[J].Am J Respir Crit Care Med,2002,166 (2):159-165.
  • 2中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J].中华结核和呼吸杂志,2002,25(4):195-198. 被引量:1842
  • 3Semenov AV,Kogan-Ponomarev MLA,Ruda MLA,Dramen R,Weran DF.Soluble P-seletion-a marker of platelet activation and vessel wall injury:increase of soluble P-seletin in plasma of patients with myocardial infarction,massive atherosclerosis and primary pulmonary hypertension[J].Ter Arkh,2000,72 (1):15-20.
  • 4Anderson TJ.Assessment and treatment of endothelial dysfunction in human[J].J Mol Cell Cardio,1999,34 (2):631-638.
  • 5IP MS,Lam B,Chan LY,Zheng L,Tsang KW,Fung PC,et al.Circulating Nitric Oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure[J].Am J Respir Crit Care Med,2000,162 (5):2 166-171.
  • 6Robinson GV,Pepperell JC,Segal HC,Davies RJ,Stradling JR.Circulationcardiovascular risk facyors in obstructive sleep aponea:date from randomised controlled trials[J].Thorax,2004,59 (9):777-782.
  • 7Saarelainen S,Seppala E,Laasonen K,Hasan J.Circulating endothelin-1 in obstructive sleep apnea[J].Endothelium,1997,5 (2):115-118.
  • 8Vogel RA.Heads and hearts:the endothelial connection[J].Circulation,2003,107 (22):2 766-768.
  • 9Lavie L.Obstructive sleep apnea syndrome:an oxidative stress disorder[J].Sleep Med Rev,2003,7 (1):35-51.
  • 10Kraiczi H,Caidahl K,Samuelsson A,Peker Y,Hedner J.Impairment of vascular endothelial function[J].Chest,2001,119 (4):1 085-091.

二级参考文献23

  • 1[1]Young T,Palta M,Dempsey J,et al.The occurrence of sleep-disordered breathing among middle-aged adults.N Engl J Med,1993,328(8):1230.
  • 2[2]Peppard PE,Young T,Palta M,et al.Prospective study of the association between sleep-disordered breathing and hypertention.N Engl J Med,2000,342(9):1378.
  • 3[3]Shahar E,Whitney CW,Redline S,et al.Sleep-disordered breathing and cardiovascular disease:cross-sectional results of the Sleep Heart Study.Am J Respir Crit Care Med,2001,163(1)19.
  • 4[4]Parra O,Arboix A,Bechich S,et al.Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack.Am J Respir Crit Care Med,2000,161(1)375.
  • 5[6]Nancl S,Messmore H.Hemostasis in malinancy.Am J Hematol,1990,35:45.
  • 6[7]Bokinsky G,Michael M,Ault K,et al.Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal countinuous positive airway pressure.Chest,1995,108(3):625.
  • 7[10]Micelson AD.Thrombin-induced down-regulation of the platelet membrance glycoprotein IB-IX.Semin Thromb Heamost,1992,18(1):18 Haemost,1992,68:378.
  • 8Lavie Lena.Obstructive sleep apnoea syndrome--an oxidative stress disorder[J].Sleep Med Rev,2003,7:35-51.
  • 9Tahawi Z,Orolinova N,Joshua IG,et al.Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats[J].J Appl Physiol,2001,90(5):2002-2013.
  • 10Kraiczi H,Caidahl K,Samuelsson A,et al.Impairment of vascular endothelial function and left ventricular filling:association with the severity of apnea-induced hypoxemia during sleep[J].Chest,2001,119:1085-1091.

共引文献1851

同被引文献71

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部